WCG Velos is a biotechnology, health care, and information technology company that offers a trusted technology platform aiming to reduce costs, enhance efficiency, improve clinical data quality, and deliver better patient care. Their flagship product, Velos eResearch, is a web-based Clinical Research Management System (CRMS) that connects financial, administrative, and clinical research activities. With over 2,000 user sites, including hospitals, health systems, and research organizations, Velos has managed over 30,000 clinical studies and half a million subject data. Founded in 1996, the company is headquartered in Fremont, California.
Velos has amassed a substantial user base, including 38 academic medical centers, 10 non-AMC health systems, 24 CTSAs, and 43 cancer centers, notably 20 NCI-designated cancer centers. The company's rich feature set and configurable workflows allow for seamless adaptation to diverse clinical research needs. With a strong presence in the industry and a record of successful application, the company presents a promising investment opportunity for venture capitalists seeking to support advancements in clinical research and technology.